{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:28:35Z","timestamp":1790771315051,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10549-025-07768-6","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:44:54Z","timestamp":1754030694000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of upstaging in DCIS: the dominant role of pathological over imaging risk factors"],"prefix":"10.1007","volume":"213","author":[{"given":"Sunhyung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bombi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Gyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seeyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Sung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Youn","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai-Hong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"3","key":"7768_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/cancers12030609","volume":"12","author":"L Salvatorelli","year":"2020","unstructured":"Salvatorelli L et al (2020) Ductal carcinoma in situ of the breast: An update with emphasis on radiological and morphological features as predictive prognostic factors. Cancers (Basel) 12(3):609. https:\/\/doi.org\/10.3390\/cancers12030609","journal-title":"Cancers (Basel)"},{"issue":"6","key":"7768_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.pathol.2019.07.005","volume":"51","author":"SS Badve","year":"2019","unstructured":"Badve SS, G\u00f6kmen-Polar Y (2019) Ductal carcinoma in situ of breast: Update 2019. Pathology 51(6):563\u2013569. https:\/\/doi.org\/10.1016\/j.pathol.2019.07.005","journal-title":"Pathology"},{"issue":"3","key":"7768_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semradonc.2022.01.005","volume":"32","author":"CA Knowlton","year":"2022","unstructured":"Knowlton CA, Jimenez RB, Moran MS (2022) DCIS: Risk assessment in the molecular era. Semin Radiat Oncol 32(3):189\u2013197. https:\/\/doi.org\/10.1016\/j.semradonc.2022.01.005","journal-title":"Semin Radiat Oncol"},{"issue":"10","key":"7768_CR4","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/1055-9965.EPI-10-0769","volume":"19","author":"LA Habel","year":"2010","unstructured":"Habel LA et al (2010) Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev 19(10):2488\u20132495. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0769","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"7768_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.46268\/jsu.2019.6.2.38","volume":"6","author":"KH Lee","year":"2019","unstructured":"Lee KH et al (2019) Clinical predictors of upstaging to invasive cancer postoperatively in patients diagnosed with ductal carcinoma in situ before surgery. J Surg Ultrasound 6(2):38\u201345. https:\/\/doi.org\/10.46268\/jsu.2019.6.2.38","journal-title":"J Surg Ultrasound"},{"issue":"3","key":"7768_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-023-06934-y","volume":"199","author":"T Ma","year":"2023","unstructured":"Ma T et al (2023) Should low-risk DCIS lose the cancer label? An evidence review. Breast Cancer Res Treat 199(3):415\u2013433. https:\/\/doi.org\/10.1007\/s10549-023-06934-y","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"7768_CR7","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","volume":"28","author":"U Rudloff","year":"2010","unstructured":"Rudloff U et al (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28(23):3762\u20133769. https:\/\/doi.org\/10.1200\/JCO.2009.26.8847","journal-title":"J Clin Oncol"},{"issue":"5","key":"7768_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jso.24037","volume":"112","author":"T Kondo","year":"2015","unstructured":"Kondo T et al (2015) A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast. J Surg Oncol 112(5):476\u2013480. https:\/\/doi.org\/10.1002\/jso.24037","journal-title":"J Surg Oncol"},{"issue":"2","key":"7768_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2020.263","volume":"53","author":"S Hong","year":"2021","unstructured":"Hong S et al (2021) Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004\u20132018. Cancer Res Treat 53(2):330\u2013338. https:\/\/doi.org\/10.4143\/crt.2020.263","journal-title":"Cancer Res Treat"},{"issue":"12","key":"7768_CR10","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","volume":"24","author":"LJ Grimm","year":"2017","unstructured":"Grimm LJ et al (2017) Surgical upstaging rates for vacuum assisted biopsy proven DCIS: Implications for active surveillance trials. Ann Surg Oncol 24(12):3534\u20133540. https:\/\/doi.org\/10.1245\/s10434-017-6018-9","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"7768_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12893-021-01170-x","volume":"21","author":"YD Shin","year":"2021","unstructured":"Shin YD, Lee HM, Choi YJ (2021) Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: A retrospective analysis. BMC Surg 21(1):159. https:\/\/doi.org\/10.1186\/s12893-021-01170-x","journal-title":"BMC Surg"},{"issue":"1","key":"7768_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12032-022-01876-9","volume":"40","author":"I Akrida","year":"2022","unstructured":"Akrida I, Mulita F (2022) The clinical significance of HER2 expression in DCIS. Med Oncol 40(1):16. https:\/\/doi.org\/10.1007\/s12032-022-01876-9","journal-title":"Med Oncol"},{"issue":"7","key":"7768_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/modpathol.2017.21","volume":"30","author":"JB Pang","year":"2017","unstructured":"Pang JB et al (2017) Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Mod Pathol 30(7):952\u2013963. https:\/\/doi.org\/10.1038\/modpathol.2017.21","journal-title":"Mod Pathol"},{"issue":"13","key":"7768_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01.COT.0000574924.92586.67","volume":"41","author":"M Perron","year":"2019","unstructured":"Perron M (2019) Overtreatment of DCIS: New Meta-analysis identifies prognostic factors. Oncology Times 41(13):19\u201320. https:\/\/doi.org\/10.1097\/01.COT.0000574924.92586.67","journal-title":"Oncology Times"},{"issue":"4","key":"7768_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ejso.2021.10.030","volume":"48","author":"G Farante","year":"2022","unstructured":"Farante G et al (2022) Advances and controversies in management of breast ductal carcinoma in situ (DCIS). Eur J Surg Oncol 48(4):736\u2013741. https:\/\/doi.org\/10.1016\/j.ejso.2021.10.030","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"7768_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.breast.2012.06.009","volume":"21","author":"C Trentin","year":"2012","unstructured":"Trentin C et al (2012) Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: Experience of 733 cases. Breast 21(5):635\u2013640. https:\/\/doi.org\/10.1016\/j.breast.2012.06.009","journal-title":"Breast"},{"issue":"1","key":"7768_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1524-4741.2007.00525.x","volume":"14","author":"R Sakr","year":"2008","unstructured":"Sakr R et al (2008) Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Breast J 14(1):55\u201360. https:\/\/doi.org\/10.1111\/j.1524-4741.2007.00525.x","journal-title":"Breast J"},{"issue":"3","key":"7768_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0960-9776(03)00024-9","volume":"12","author":"TM Allweis","year":"2003","unstructured":"Allweis TM, Badriyyah M, Bar AdV, Cohen T, Freund HR (2003) Current controversies in sentinel lymph node biopsy for breast cancer. Breast 12(3):163\u2013171. https:\/\/doi.org\/10.1016\/s0960-9776(03)00024-9","journal-title":"Breast"},{"issue":"2","key":"7768_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12282-020-01187-9","volume":"28","author":"H Maeda","year":"2021","unstructured":"Maeda H et al (2021) Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US). Breast Cancer 28(2):398\u2013404. https:\/\/doi.org\/10.1007\/s12282-020-01187-9","journal-title":"Breast Cancer"},{"issue":"1","key":"7768_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/mco.2020.2036","volume":"13","author":"G Oda","year":"2020","unstructured":"Oda G et al (2020) Predictors for upstaging of ductal carcinoma in situ (DCIS) to invasive carcinoma in non-mass-type DCIS. Mol Clin Oncol 13(1):67\u201372. https:\/\/doi.org\/10.3892\/mco.2020.2036","journal-title":"Mol Clin Oncol"},{"issue":"11","key":"7768_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3349\/ymj.2019.60.11.1028","volume":"60","author":"S Kim","year":"2019","unstructured":"Kim S et al (2019) An updated nomogram for predicting invasiveness in preoperative ductal carcinoma in situ of the breast. Yonsei Med J 60(11):1028\u20131035. https:\/\/doi.org\/10.3349\/ymj.2019.60.11.1028","journal-title":"Yonsei Med J"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07768-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:37:20Z","timestamp":1756438640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7768"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07768-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the National Cancer Center (IRB approval No. NCC2024-0293, Date: January 23, 2025).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study utilized retrospective data that were collected for clinical purposes before the study commenced. Since no direct interaction with participants was involved, informed consent was not required. All data were anonymized and handled in accordance with ethical guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}